Gritstone Oncology, Inc.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Emeryville CA United States (2015)

Organization Overview

First Clinical Trial
2018
NCT03639714
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Gritstone Oncology | Gritstone Oncology, Inc.